Secrets to label-free protein analysis in a shared resource lab

Join us Tuesday, July 6, to discover how to optimize your biomolecular interaction analyses for higher throughput and efficiency

28 Jun 2021

Ellen Simms

Product and Reviews Editor

Detecting and quantifying biomolecular interactions is critical in therapeutics development and life sciences research. Choosing a biosensor platform to suit your application and workflow requires careful consideration of key attributes such as throughput, sample capacity, unattended runtimes, affinity ranges, sensitivity, type of sample matrix and ease of use.

In this webinar, Dr. Patrick England, Head of Molecular Biophysics at Institut Pasteur, Paris, will highlight how using bio-layer interferometry (BLI) based Octet^® systems can provide a fast and straightforward means to accurately determine binding specificity, affinity, and kinetics, and will outline how to optimize the use of these systems from a quantitative and qualitative standpoint.

Dr. England will discuss how the Octet^®RED384 system has proved to be one of the most popular systems to characterize biomolecular interactions since its installation in Institut Pasteur and will provide guidance on how to effectively manage its use for the maximum benefit of a large and diverse scientific community.

Key learning objectives

Capabilities and advantages of BLI technology for label-free biomolecular interaction analysis in biologics development and life sciences research
How to optimize the use of an Octet^® instrument in an institutional life science core facility, from a quantitative and qualitative standpoint

Who should attend?

Scientists using or wishing to use label-free screening and characterization of protein-protein or protein-drug interactions in a multi-user/multi-project context
Non-experts wishing to learn more about BLI technology, capabilities, and advantages for biologics development and life sciences research.

The live webinar takes place on Tuesday, July 6, at: